Funding for this research was provided by:
National Institute for Health Research
Text and Data Mining valid from 2019-07-11
Received: 28 March 2019
Accepted: 1 July 2019
First Online: 11 July 2019
Ethics approval and consent to participate
: The study protocol was approved in March 2014 by the Newcastle Research Ethics Committee (ref: REC-14-NE-0026) and sample collections took place between April 2014 and November 2015. Patients were recruited with written informed consent through UTI clinics led by the Urology Department at Freeman Hospital, Newcastle upon Tyne, UK.
: Not applicable.
: LD, WR, CM, JH, PA declare no conflicts of interest. CH declares advisory/consultancy roles for Pierre Fabre, AMS and Astellas and speaker roles for Astellas, Pfizer, Ferring, Allergan and Medtronic.